These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7375679)

  • 1. [Enhancement of 67Ga tumor-to-blood ratios by chelating agent (author's transl)].
    Saji H; Yokoyama A; Hata N; Misaki A; Tanaka H; Morita R; Fukunaga M; Torizuka K
    Radioisotopes; 1980 Jan; 29(1):7-12. PubMed ID: 7375679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The influence of iron on 67Ga distribution in tumor-bearing mice--effect of iron administered after 67Ga injection (author's transl)].
    Higashi T; Shimura A; Wakao H
    Radioisotopes; 1981 Jul; 30(7):385-90. PubMed ID: 7323324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of iron on 67Ga distribution in tumor-bearing mice--effect of iron administered before 67Ga injection (author's transl)].
    Shimura A; Higashi T; Wakao H
    Radioisotopes; 1981 Jul; 30(7):379-84. PubMed ID: 7323323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor uptake of 67Ga-carrying liposomes.
    Ogihara I; Kojima S; Jay M
    Eur J Nucl Med; 1986; 11(10):405-11. PubMed ID: 3699065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [103Ru for tumor scanning--a comparative study on tissue distributions of 103Ru-chloride and 103Ru-citrate in tumor-bearing animals (author's transl)].
    Mizukawa K; Yamamoto G; Tamai T; Tanabe M; Yamamoto M
    Radioisotopes; 1978 May; 27(5):245-50. PubMed ID: 674703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desferoxamine mesylate (Desferal): a contrast-enhancing agent for gallium-37 imaging.
    Hoffer PB; Samuel A; Bushberg JT; Thakur M
    Radiology; 1979 Jun; 131(3):775-9. PubMed ID: 441388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased delivery of gallium-67 to tumors using serum-stable liposomes.
    Ogihara-Umeda I; Kojima S
    J Nucl Med; 1988 Apr; 29(4):516-23. PubMed ID: 3351606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of labeling efficiency, biological activity and biodistribution among 125I-, 67Ga-DTPA-and 67Ga-DFO-lectins.
    Kojima S; Jay M
    Eur J Nucl Med; 1987; 13(7):366-70. PubMed ID: 3428286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 67Ga-citrate accumulation by tumors: importance of magnesium and calcium metabolism.
    Anghileri LJ
    Strahlentherapie; 1973 Sep; 146(3):359-66. PubMed ID: 4778525
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of oncophilic radiopharmaceuticals, *I-fibrinogen, 67Ga-citrate, 111In-bleomycin, and *I-bleomycin in tumor-bearing mice.
    DeNardo GL; Krohn KA; DeNardo SJ
    Cancer; 1977 Dec; 40(6):2923-9. PubMed ID: 73412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chelator-induced enhancement of 67Ga tumour imaging: comparison of desferrioxamine with N,N'-ethylene-bis[2-hydroxy-5-carboxyphenylglycine].
    Hunt FC
    Int J Rad Appl Instrum B; 1988; 15(6):651-7. PubMed ID: 3251899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell labelling with 67Ga-citrate.
    Anghileri LJ
    Int J Rad Appl Instrum B; 1991; 18(2):259-60. PubMed ID: 2026504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies of radiocitrates in oncological models--I. 99mTc citrate and 67Ga citrate uptake by EMT-6 tumors in mice.
    Gati LJ; Wiebe LI; Tse JW; Turner CJ; Noujaim AA
    Int J Rad Appl Instrum B; 1986; 13(3):253-5. PubMed ID: 3464579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron(III)-nitrilotriacetate: an agent for reducing the time interval of tumor imaging with gallium citrate.
    Saji H; Hata N; Horiuchi K; Yokoyama A; Yamamoto K; Torizuka K
    Int J Nucl Med Biol; 1985; 12(4):281-7. PubMed ID: 3866752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of iron-binding proteins on in vitro uptake of 67Ga-citrate by tumor cells.
    Anghileri LJ; Thouvenot P; Brunotte F; Crone Escanye MC; Robert J
    Int J Rad Appl Instrum B; 1990; 17(3):331-4. PubMed ID: 2341289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of lectins to tumor imaging radiopharmaceuticals.
    Kojima S; Jay M
    Eur J Nucl Med; 1986; 12(8):385-9. PubMed ID: 3466792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of chelating agents with cadmium in mice and rats.
    Eybl V; Sýkora J; Koutenský J; Caisová D; Schwartz A; Mertl F
    Environ Health Perspect; 1984 Mar; 54():267-73. PubMed ID: 6734561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental evidence for the probable involvement of calcium ion transport in 67Ga uptake by tumour cells.
    Anghileri LJ; Thouvenot P; Brunotte F; Robert J
    Eur J Nucl Med; 1986; 12(4):179-81. PubMed ID: 3769965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of desferoxamine on tissue and tumor retention of gallium-67: concise communication.
    Hoffer PB; Samuel A; Bushberg JT; Thakur M
    J Nucl Med; 1979 Mar; 20(3):248-51. PubMed ID: 24180048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A newly designed radioimmunoconjugate releasing a hippurate-like radiometal chelate for enhanced target/non-target radioactivity.
    Arano Y; Matsushima H; Tagawa M; Inoue T; Koizumi M; Hosono M; Sakahara H; Endo K; Konishi J; Yokoyama A
    Nucl Med Biol; 1994 Jan; 21(1):63-9. PubMed ID: 9234265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.